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Introduction {#sec1}
============

The mitochondrial membrane potential (Δψ~*m*~) is central to the organelle's many functions ([@bib13]). As electrons pass down the respiratory chain to oxygen, the difference in reduction potential drives proton pumping across the inner membrane, generating a proton electrochemical potential gradient comprising a pH gradient (∼0.8 pH units/50 mV, basic inside) and a Δψ~*m*~ (∼120--180 mV, negative inside); thus Δψ~m~ is by far the dominant component. The central function of Δψ~*m*~ is to drive ATP synthesis by oxidative phosphorylation, and its magnitude is set by the balance between its generation and its consumption by ATP synthesis and other dissipative processes ([Figure 1](#fig1){ref-type="fig"}A), making Δψ~m~ a sensitive indicator of cellular energetics. Δψ~*m*~ can decrease due to elevated ATP production or thermogenesis, or from mitochondrial dysfunction, while Δψ~*m*~ can increase due to diminished ATP synthesis or an upregulation of proton pumping. Such increases occur in apoptosis and cancer ([@bib26], [@bib28]). An increase in Δψ~*m*~ is also a key driver of mitochondrial ROS production in pathology and redox signaling ([@bib12]). Consequently, many biomedically central phenomena are associated with subtle changes in Δψ~m~, and the ability to quantify these alterations in vivo and in cells should enable mechanistic insights and facilitate novel approaches to diagnosis and therapies ([Figure 1](#fig1){ref-type="fig"}A).

Changes in Δψ~*m*~ within cells can be assessed using fluorescent or radiolabeled lipophilic cations; however, these approaches are insensitive to small changes ([@bib6], [@bib14]) and can only be used in restricted situations in vivo ([@bib6], [@bib24]). Hence we have developed a sensitive method to assess small changes in Δψ~*m*~ and Δψ~p~, in cells and in vivo. For this we direct probes to mitochondria using a triphenylphosphonium (TPP) lipophilic cation ([@bib20], [@bib25], [@bib26]). The large hydrophobic surface area of the TPP cation enables its rapid, several-hundred-fold accumulation into cells in response to the Δψ~p~ and from there into mitochondria in response to Δψ~*m*~ ([@bib20]). To assess relative changes in Δψ~*m*~ and Δψ~p~, we administer two TPP compounds simultaneously, both of which accumulate within mitochondria and react together to form a stable product ([Figure 1](#fig1){ref-type="fig"}B). The reaction rate is proportional to the local concentrations of both reactants, each of which accumulates in mitochondria ∼10^2^- to 10^3^-fold driven by Δψ~p~ and Δψ~*m*~, hence product formation there will be ∼10^4^- to 10^6^-fold faster than that in the cytosol and will be extremely sensitive to small changes in Δψ~m~ and Δψ~p~ ([Figure 1](#fig1){ref-type="fig"}B).

For this to work, the two probes must react specifically with each other and not with other biomolecules. To achieve this, we used "click" chemistry, which utilizes azido and alkyne groups, which couple ex vivo under Cu(I) catalysis ([@bib11]). To enable the reaction to occur in vivo without catalysis, Bertozzi developed strained cyclooctynes ([@bib1], [@bib7]). Therefore we prepared TPP compounds containing cyclooctyne (MitoOct) and azido (MitoAzido) moieties, which react together to form MitoClick ([Figure 1](#fig1){ref-type="fig"}B).

The rate of the reaction of MitoOct with MitoAzido to form MitoClick is$$Rate_{MitoClick} = K\left\lbrack {MitoAzido} \right\rbrack\left\lbrack {MitoOct} \right\rbrack$$where *k* is the second order rate constant. As shown in [Supplemental Information](#app2){ref-type="sec"}, available online, the ratio of the rates of MitoClick formation in mitochondria and cytosol is$$\frac{Rate_{Mito}}{Rate_{Cyto}} = 10^{\frac{2\Delta\psi_{m}}{2.303RT}} = 10^{\frac{2\Delta\psi_{m}}{31}}.$$

Thus, there is an exponential dependence of the rate enhancement on Δψ~*m*~ over the biologically relevant range from 120 to 180 mV ([Figure 1](#fig1){ref-type="fig"}C) ([@bib3], [@bib16]), assuming no confounding changes in Δψ~p~. Differentiation of [Equation 2](#fd2){ref-type="disp-formula"} gives$$\frac{d\left( \frac{Rate_{Mito}}{Rate_{Cyto}} \right)}{d\Delta\psi_{m}} = \frac{Ln10}{31}10^{\frac{\Delta\psi_{m}}{31}}.$$

Therefore every 1 mV Δψ~*m*~ increase accelerates mitochondrial MitoClick formation relative to that in the cytosol ∼800-fold at 120 mV and ∼80,000-fold at 180 mV. This leads to an 8% compounded increase in MitoClick formation per mV, making very small relative changes in Δψ~m~ easy to assess ([Figure 1](#fig1){ref-type="fig"}C). It is essential to note that, as with all methods dependent on lipophilic cation accumulation, the accumulation of MitoClick will also be sensitive to small changes in Δψ~p~. Alteration of mitochondrial, cell, and extracellular volumes, and excretion and binding, will also affect the rate of MitoClick formation. Consequently, while in all cases small changes in Δψ~*m*~ will dramatically alter MitoClick formation rate, it is vital to consider the many confounding factors that could impact on measurements.

To quantify the amount of MitoClick formed within tissues, we use liquid chromatography-tandem mass spectrometry (LC-MS/MS) relative to deuterated internal standards, which enables sensitive detection of TPP probes ([@bib5]). Here we describe the development and application of mitochondria-targeted click reagents to assess small changes of Δψ~m~ in cells and in vivo.

Results and Discussion {#sec2}
======================

Uptake of MitoOct and MitoAzido Forms MitoClick within Energized Mitochondria {#sec2.1}
-----------------------------------------------------------------------------

The syntheses of MitoOct and MitoAzido are shown in [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B. Reaction of MitoOct with MitoAzido gave only MitoClick ([Figure S1](#mmc1){ref-type="supplementary-material"}C) as a 1:1 mixture of regioisomers, determined by ^1^H-NMR and high-resolution mass spectrometry ([Supplemental Information](#app2){ref-type="sec"}). RP-HPLC also showed that MitoOct and MitoAzido reacted together to form MitoClick under biological conditions ([Figure 2](#fig2){ref-type="fig"}A). We used an ion-selective electrode to show that MitoOct and MitoAzido were taken up by energized mitochondria and released upon dissipation of Δψ~*m*~ with the uncoupler carbonylcyanide-*p*-trifluoromethoxyphenylhydrazone (FCCP) ([Figure 2](#fig2){ref-type="fig"}B). The uptake for MitoOct or MitoAzido (∼1--1.5 nmol/mg protein) ([Figure 2](#fig2){ref-type="fig"}B), corresponds to 2--3 mM in the matrix (assuming ∼0.5 μl/mg protein \[[@bib22]\] and uncorrected for binding), ∼1,000-fold greater than the external concentration (∼3 μM), consistent with Δψ~*m*~-dependent uptake. MitoClick mitochondrial uptake was ∼3--3.5 nmol/mg protein ([Figure 2](#fig2){ref-type="fig"}B), about 6--7 mM in the matrix, ∼10,000-fold greater than the external concentration (∼0.5 μM), more than its monocationic precursors, as expected for a dication ([@bib21]).

To see if MitoClick formation was enhanced by mitochondrial accumulation of its precursors, we incubated MitoOct and MitoAzido with mitochondria and measured MitoClick formation ([Figure 2](#fig2){ref-type="fig"}C). There was extensive MitoClick generation after 1 min with mitochondria ([Figure 2](#fig2){ref-type="fig"}C), compared to negligible formation over 1 hr without mitochondria ([Figure 2](#fig2){ref-type="fig"}A), and this MitoClick formation was prevented by FCCP ([Figure 2](#fig2){ref-type="fig"}C). Therefore, both MitoOct and MitoAzido are extensively accumulated by mitochondria in response to Δψ~m~, dramatically increasing the rate of MitoClick formation.

LC-MS/MS Analysis of MitoClick Formation from MitoOct and MitoAzido {#sec2.2}
-------------------------------------------------------------------

The measurement of MitoClick formation in vivo necessitates LC-MS/MS detection, because RP-HPLC is too insensitive. However, LC-MS/MS requires solvent extraction followed by evaporation under vacuum ([@bib5]), greatly concentrating unreacted MitoAzido and MitoOct which would lead to extensive ex vivo MitoClick formation. To prevent this we used a blocking reagent, 3-phenyl-1,2,4,5-tetrazine (Tet), which reacts very rapidly with MitoOct to generate MitoOct~*tet*~ ([Figure S2](#mmc1){ref-type="supplementary-material"}A) ([@bib10]). The reaction of Tet with MitoOct (k ∼12.1 × 10^6^ M^−1^s^−1^ \[[@bib2]\]) is ∼10^8^-fold faster than that for MitoAzido (k ∼0.1--0.2 M^−1^s^−1^). Including Tet in the extraction solution prevented artifactual MitoClick formation ([Figure S2](#mmc1){ref-type="supplementary-material"}B; [Table S1](#mmc1){ref-type="supplementary-material"}).

To establish LC-MS/MS assays, we fragmented MitoClick, MitoOct~*tet*~, and MitoAzido and analyzed the product ions to select mass transitions for quantification ([Table S2](#mmc1){ref-type="supplementary-material"}). These transitions are selective for the intended species by LC-MS/MS ([Figure 2](#fig2){ref-type="fig"}D). From these, standard curves were established for MitoAzido, MitoOct~*tet*~ and MitoClick in tissue homogenates with detection down to ∼1--5 pmol per g wet weight tissue ([Figure S2](#mmc1){ref-type="supplementary-material"}C). This approach was used to assess the rate of reaction of MitoOct and MitoAzido in solution ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E).

Analysis of MitoClick Formation in Mitochondria and Cells {#sec2.3}
---------------------------------------------------------

Formation of MitoClick from MitoAzido and MitoOct in isolated mitochondria was assessed by LC-MS/MS ([Figure 3](#fig3){ref-type="fig"}A). The levels of MitoOct~*tet*~ and MitoAzido were stable over 5 min, while MitoClick increased, consistent with formation in mitochondria ([Figure 3](#fig3){ref-type="fig"}A). Abolition of Δψ~m~ with FCCP prevented MitoClick formation, while increasing Δψ~m~ with nigericin increased its generation ([Figure 3](#fig3){ref-type="fig"}B). Gradually decreasing Δψ~m~ with the respiratory inhibitor malonate led to a corresponding decrease in MitoClick ([Figure 3](#fig3){ref-type="fig"}C). Thus MitoClick formation in mitochondria is sensitive to small changes in Δψ~m~.

When we incubated MitoAzido and MitoOct with cells, MitoClick increased over time in both the supernatant and cells ([Figure 3](#fig3){ref-type="fig"}D). To see how MitoClick formation responded to small changes of Δψ~m~, we assessed Δψ~m~ alterations that are likely to occur in cells, illustrated by oxygen consumption rate (OCR) measurements ([Figure 3](#fig3){ref-type="fig"}E). Under basal respiration, mitochondria make ATP and have a submaximal Δψ~m~; oligomycin inhibits ATP synthesis maximizing Δψ~m~ and decreasing OCR; finally, FCCP abolishes Δψ~m~ and maximizes OCR ([Figure 3](#fig3){ref-type="fig"}E). The associated subtle changes in Δψ~m~ are less easily assessed, as is illustrated using a current benchmark for Δψ~m~ investigation, the fluorescence of tetramethylrhodamine (TMRM) in nonquenching mode ([Figures 3](#fig3){ref-type="fig"}F and 3G). Increasing Δψ~m~ from its normal value to its maximum with oligomycin gave only a small change in fluorescence ([Figures 3](#fig3){ref-type="fig"}F and 3G). In contrast, the same increase in Δψ~m~ dramatically enhanced MitoClick formation ([Figure 3](#fig3){ref-type="fig"}H). Similarly, inhibition of respiration by rotenone and/or antimycin showed a far greater change in MitoClick than TMRM ([Figures 3](#fig3){ref-type="fig"}I and 3J). Subsequent addition of oligomycin further lowered Δψ~m~ by inhibiting proton pumping by the ATP synthase ([Figures 3](#fig3){ref-type="fig"}I and 3J). Therefore MitoClick formation is exquisitely sensitive to small changes in Δψ~m~ within cells ([Figure 1](#fig1){ref-type="fig"}C).

Use of MitoClick Formation to Assess Relative Changes in Δψ~m~ within Mice {#sec2.4}
--------------------------------------------------------------------------

Methods to assess subtle changes in Δψ~m~ in mice in vivo have long been sought. TPP can target a wide range of compounds to mitochondria within mice, following intravenous (i.v.) administration with rapid (minutes) mitochondrial uptake within the heart, liver, and kidney ([@bib17], [@bib18], [@bib25], [@bib26]). MitoAzido and MitoOct could be given safely i.v. by tail vein injection to mice; therefore over the next 3 hr we measured their levels and those of MitoClick in the heart ([Figure 4](#fig4){ref-type="fig"}A). There was an initial increase in MitoOct and MitoAzido content, as expected due to the rapid uptake of TPP compounds by the heart in response to Δψ~p~ and Δψ~m~ ([@bib17], [@bib18]). These compounds were lost with half-lives of ∼0.8 hr, due to their re-equilibration across membranes followed by excretion in the urine and bile ([@bib25]). There was rapid initial MitoClick formation, due to the high MitoAzido and MitoOct mitochondrial concentrations immediately following injection ([Figure 4](#fig4){ref-type="fig"}A). MitoClick formation was sustained for a short time and then stopped, as the precursors became depleted ([Figure 4](#fig4){ref-type="fig"}A). MitoClick was retained longer due to its double positive charge ([@bib21]) ([Figure 4](#fig4){ref-type="fig"}A). The kidney showed less MitoAzido and MitoOct uptake than the heart, and the apparent rate of excretion was slower, consistent with redistribution from other organs ([Figure S3](#mmc1){ref-type="supplementary-material"}B). There was uptake of MitoAzido and MitoOct into the liver ([Figure S3](#mmc1){ref-type="supplementary-material"}B); however, MitoOct and MitoClick were rapidly lost from this tissue, probably due to excretion by the biliary pathway ([@bib18]). These findings suggest that the rapid initial formation of MitoClick in the heart following a single i.v. injection of its precursors may be used to infer changes in Δψ~p~ and Δψ~m~ in vivo. However, it is important to note that the factors that determine MitoClick formation in vivo are quite different from those that dominate for cells in culture. In vivo, MitoOct and MitoAzido do not have the opportunity to equilibrate with Δψ~p~ and Δψ~m~ as they do in cells. In contrast, kinetic factors such as blood flow, tissue uptake, and excretion determine the initial uptake into cells and mitochondria. Even so, the local concentration of MitoOct and MitoAzido within mitochondria by Δψ~p~ and Δψ~m~ suggests that the initial formation of MitoClick in tissues reports on changes in these potentials.

The response of MitoClick formation to changes in Δψ~m~ in the heart was evaluated using the uncoupler 2,4-dinitrophenol (DNP). Uncoupling by DNP leads to pathological heat generation in vivo and is known to decrease Δψ~m~ ([@bib8]). DNP decreased the formation of MitoClick indicating that this approach can be used to assess changes in Δψ~m~ within the heart in vivo ([Figures 4](#fig4){ref-type="fig"}B and 4C). MitoClick could be used to assess the toxic effects of DNP and assist in the development of safer formulations ([@bib15]); however, we note that the response of MitoClick formation in vivo to DNP administration route and dose was not straightforward, presumably due to DNP distribution and compensatory changes in mitochondrial respiration and Δψ~m~. Next, we used MitoClick to assess whether there was a change in Δψ~m~ in a mouse model of heart mitochondrial dysfunction. We used a heart-specific *Ndufs4*-null strain ([@bib4], [@bib9], [@bib27]). *Ndufs4* encodes an 18 kDa subunit of respiratory complex I that plays a role in assembly and/or stability of the complex ([@bib9]). The *Ndufs4*-null mice had an ∼50% decrease in complex I activity in the heart, and developed severe cardiomyopathy ([@bib4], [@bib9]). We confirmed the decreased complex I activity ([Figure 4](#fig4){ref-type="fig"}D), and therefore expected to find a decrease in Δψ~m~ in the heart due to defective proton pumping. To our great surprise, MitoClick formation was actually elevated compared to control mice ([Figure 4](#fig4){ref-type="fig"}E). One possibility was that MitoClick formation increased within *Ndufs4*-null hearts due to a compensatory increase in mitochondrial content. However, the mitochondrial marker enzyme citrate synthase showed no such increase ([Figure 4](#fig4){ref-type="fig"}F). To see if there was a change in mitochondrial energetics, we assessed isolated heart mitochondria in vitro, and this showed that heart mitochondria from the *Ndufs4*-null mice had a higher Δψ~m~ when respiring on succinate ([Figure 4](#fig4){ref-type="fig"}G), suggesting a compensatory upregulation of Δψ~m~ generation from complex II-linked substrates to counteract the complex I-linked defect in the hearts of *Ndufs4*-null mice. This surprising result inadvertently provided a good test for MitoClick and showed that it can assess unexpected small changes in Δψ~m~ in vivo. However, it is important to note that further work is required to determine whether the relative change in MitoClick formation in these mice could be in part due to changes in Δψ~p~ or mitochondrial volume. Even so, these findings with the *Ndufs4*-null mice show how MitoClick can contribute to investigating subtle changes to Δψ~m~ in the heart in vivo.

Conclusion {#sec2.5}
----------

As Δψ~m~ is central to mitochondrial function and dysfunction, subtle changes are of considerable significance for cell fate and health. The difficulty of assessing small changes in Δψ~m~ in cells and in vivo is a major impediment to understanding normal and pathological mitochondrial function in a range of biomedically important situations. Here we have developed a highly sensitive approach that can contribute to the assessment of Δψ~m~ in cells and in vivo, and shown its utility in proof of principle experiments.

A unique aspect of the approach is that it utilizes Δψ~m~- and Δψ~p~-dependent uptake and reaction together of two cations to form a diagnostic product, MitoClick. Consequently, the rate of MitoClick formation is particularly sensitive to small changes in Δψ~m~ and Δψ~p~ due to the logarithmic relationship of uptake of both cations to these potentials. Transformation of potential measurement from a reversible compound distribution to an irreversible reaction rate circumvents the hitherto intractable problem of compound redistribution during sample work up. Consequently, changes in Δψ~m~ and Δψ~p~ can be assessed in vivo, within whole organs or organisms, and the MitoClick approach opens up new ways of exploring subtle mitochondrial changes.

There are constraints to this approach that should be borne in mind. The first is that uptake of MitoAzido and MitoOct within mitochondria will also be affected by Δψ~p~; therefore changes in this variable must also be considered before concluding that MitoClick formation is related to an alteration to Δψ~m~. A further point is that MitoClick formation is the weighted mean of all mitochondria analyzed, and therefore gives average values of Δψ~m~ and Δψ~p~ in the sample. Complementary methods will be required to assess whether Δψ~m~ or Δψ~p~ changes in individual cells or mitochondria. It is also important to consider whether changes in MitoClick formation are influenced by mitochondrial content, as was addressed herein by measurement of a marker enzyme. A related consideration is that the local rate of formation of MitoClick will be affected by changes in the organelle volume. Therefore, although MitoClick formation is exquisitely sensitive to subtle changes in Δψ~m,~ this very sensitivity means that we must be cautious in ascribing changes in MitoClick formation solely to Δψ~m~. However, these limitations apply to most methods routinely used to assess Δψ~m~ in cells.

The concentration of two TPP compounds simultaneously within mitochondria to assemble a new compound suggests that mitochondria can be used as a "reaction chamber." This could facilitate the generation of new bioactive, therapeutic, or toxic compounds locally within mitochondria, but with the precursors having minimal effects. This approach has been suggested previously, but using nonspecific functions ([@bib19], [@bib23]); thus the development of TPP-conjugated click reagents opens up a new methodology for future development.

To conclude, we have shown that it is possible to assess small changes in Δψ~m~ and Δψ~p~ in cells in culture and in vivo using of mitochondria-targeted click reagents. This development opens up many new possibilities for assessing changes in these potentials in physiological and pathological processes.

Experimental Procedures {#sec3}
=======================

Synthesis and In Vitro Analysis of MitoAzido, MitoOct, and MitoClick {#sec3.1}
--------------------------------------------------------------------

The syntheses and characterization of MitoAzido, MitoOct, and MitoClick and their deuterated internal standards (IS) are described in the [Supplemental Information](#app2){ref-type="sec"}.

Cell Culture {#sec3.2}
------------

C2C12 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% FCS. To assess Δψ~m~ by fluorescent microscopy, we used TMRM as described in the [Supplemental Information](#app2){ref-type="sec"}.

Mouse Experiments {#sec3.3}
-----------------

All animal experiments were carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 and the University of Cambridge Animal Welfare Policy. For the time course studies, male 8- to 10-week-old C57BL/6 mice were used. The heart-specific *Ndufs4*-null strain was a gift from Nils-Göran Larsen, Köln ([@bib4], [@bib27]). Mice were administered MitoOct and MitoAzido by tail vein injection and were then killed by cervical dislocation with tissues being isolated and snap-frozen on liquid nitrogen. MitoOct, MitoAzido, and MitoClick were extracted from the mouse tissues as described in the [Supplemental Information](#app2){ref-type="sec"}.

LC-MS/MS Analysis {#sec3.4}
-----------------

Samples were analyzed by LC-MS/MS with multiple reaction monitoring in positive ion mode after reverse-phase separation on an I-class Acquity LC attached to a Xevo TQ-S triple quadrupole mass spectrometer (Waters), analyzed using MassLynx software. Standard curves were prepared and processed in parallel using the appropriate biological material or buffer spiked with *d*~*15*~-MitoOct, *d*~*15*~-MitoAzido, and *d*~*30*~-MitoClick ISs and various amounts of MitoOct~tet~, MitoAzido, and MitoClick. Standard curves for the response of MitoOct~*tet*~, MitoAzido, and MitoClick relative to its deuterated IS against concentration were linear over the range 1--1,000 pmol with R^2^ routinely \>0.99 (see [Figure S3](#mmc1){ref-type="supplementary-material"}D).
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====================
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![Rationale for Mitochondria-Targeted Click Chemistry to Assess Δψ~m~\
(A) Δψ~m~ in vivo. This shows a mitochondrion with the respiratory chain generating Δψ~m~ by pumping protons across the inner membrane. The Δψ~m~ is used to synthesize ATP. Situations in which the steady-state level of Δψ~m~ within cells and in vivo change are indicated.\
(B) The structures of MitoAzido and MitoOct are shown along with their uptake into the cell in response to the plasma membrane potential (Δψ~p~) and then into mitochondria in response to the Δψ~m~ across the inner membrane in vivo, followed by their click reaction together to form MitoClick as a regioisomeric mixture.\
(C) The rate of MitoClick formation in the mitochondrial matrix divided by the rate in the cytosol as a function of Δψ~m~, with the cytosolic concentrations of MitoAzido and MitoOct held constant. [Equation 2](#fd2){ref-type="disp-formula"}, which describes this curve, is shown. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Reaction of MitoOct and MitoAzido to Form MitoClick in Mitochondria\
(A) MitoOct and MitoAzido (10 nmol of each) were incubated in 250 μL KCl medium at room temperature for the indicated times and then analyzed by RP-HPLC. The double peak for MitoClick by RP-HPLC is due to the formation of the two MitoClick regioisomers.\
(B) Isolated mitochondria were incubated in the chamber of an ion-selective electrode, and the response was calibrated by 5 × 1 μM successive additions of MitoAzido, MitoOct, or MitoClick. Where indicated mitochondria, succinate and FCCP were added.\
(C) Mitochondria were incubated with MitoAzido (5 μM) and MitoOct (5 μM) for the indicated times, pelleted, and extracted with ACN and the extract analyzed by RP-HPLC.\
(D) Typical LC-MS/MS chromatograms showing the *m/z* transitions measured simultaneously for 50 nM each of MitoAzido, *d*~*15*~-MitoAzido, MitoOct~*tet*~, *d*~*15*~-MitoOct~*tet*~, MitoClick, and *d*~*30*~-MitoClick. Traces are normalized to the maximum total ion count measured during that experiment. See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Assessment of MitoClick Formation by LC-MS/MS in Mitochondria and Cells\
(A) Detection of MitoAzido, MitoOct~*tet*~, and MitoClick in mitochondria. Rat liver mitochondria (1 mg protein/mL) were incubated with 5 μM of MitoAzido and MitoOct in KCl medium at 37°C. Samples were removed at the indicated times, and mitochondria were pelleted, quenched with Tet, and then extracted and analyzed by LC-MS/MS. Data are means ± SEM of three separate mitochondrial preparations.\
(B) Detection of MitoClick in mitochondria. Rat liver mitochondria were incubated as in (A) for 5 min ± FCCP (500 nM) or nigericin.\
(C) Effect of malonate on MitoClick formation in mitochondria. Rat liver mitochondria were incubated as in (A) for 5 min with increasing concentrations of malonate. Samples were removed, quenched with Tet, then extracted and analyzed by LC-MS/MS. Data are means ± SEM of three replicates.\
(D) Detection of MitoAzido, MitoOct~*tet*~, and MitoClick in cells. C2C12 cells were incubated with 5 μM each of MitoAzido and MitoOct for up to 3 hr. The supernatant was removed and the cell layer was scraped into PBS, and both were quenched with Tet, extracted, and analyzed by LC-MS/MS. Data are means ± SEM of three independent experiments.\
(E) Oxygen consumption rate (OCR) measured in C2C12 cells. Where indicated, oligomycin (4 μM), FCCP (2 μM), and rotenone/antimycin (4 μg/mL) were added. Each point is the mean ± range of measurements on two wells.\
(F) Detection of changes in Δψ~m~ using TMRM staining in cells. C2C12 cells were treated with 100 nM TMRM and 500 ng/mL Hoescht 33342 for 15 min prior to imaging. Cells were imaged on a temperature-control stage of a Nikon Eclipse Ti microscope using 63× oil immersion lens. Where indicated, additions of oligomycin (4 μM) and FCCP (2 μM) were made directly to the cultured cells.\
(G) Assessment of changes in Δψ~m~ using TMRM staining in cells. Fluorescence intensity of eight cells per experiment evaluated using Nikon elements software. Data shown are means ± SEM of three independent experiments.\
(H) Effect of FCCP and oligomycin on MitoClick formation in cells. C2C12 cells were incubated with 5 μM each of MitoAzido and MitoOct alone or with oligomycin (1 μg/mL) or FCCP (2 μM) as indicated for 3 hr. The cell layer was scraped into PBS, quenched with Tet, extracted, and analyzed by LC-MS/MS.\
(I) Assessment of changes in Δψ~m~ due to mitochondrial inhibitors using TMRM staining in cells. Fluorescence intensity of eight cells per experiment after 15 min incubation was assessed as in (G). Incubations contained no further additions (control), rotenone (4 μg/mL) (rot), rotenone (4 μg/mL), and antimycin (4 μg/mL) (rot/ant) or rotenone (4 μg/mL), antimycin (4 μg/mL), and oligomycin (1 μg/mL) (rot/ant/olig). Data shown are means ± SEM of three independent experiments.\
(J) Effect of mitochondrial inhibitors on MitoClick formation in cells. C2C12 cells were incubated with 5 μM each of MitoAzido and MitoOct alone (cont) or rotenone (4 μg/mL) (rot), rotenone (4 μg/mL), and antimycin (4 μg/mL) (rot/ant) or rotenone (4 μg/mL), antimycin (4 μg/mL), and oligomycin (1 μg/mL) (rot/ant/olig) as indicated for 3 hr. The cell layer was scraped into PBS, quenched with Tet, extracted, and analyzed by LC-MS/MS. Data are means ± SEM of three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 assessed by Student's t test relative to untreated control.](gr3){#fig3}

![Assessment of MitoClick Formation by LC-MS/MS in Mice\
(A) Detection of MitoAzido, MitoOct~*tet*~, and MitoClick in mouse heart. Mice were injected i.v. with 50 nmol each of MitoAzido and MitoOct, and after the indicated times the heart was removed and MitoAzido, MitoOct~*tet*~, and MitoClick were analyzed by LC-MS/MS. Data are means ± SEM of three mice per time point. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.\
(B and C) Effect of DNP on MitoClick formation within the mouse heart. Mice were injected i.v. with 10 nmol each of MitoAzido and MitoOct at various times after DNP administration, then 1 min later the heart was removed and MitoAzido, MitoOct~*tet*~, and MitoClick analyzed by LC-MS/MS. In (B) MitoAzido and MitoOct were injected 15 min after i.p. administration of DNP (1 mg/kg). Data are means ± SEM of eight mice. In (C) mice were administered DNP (5 mg/kg) by oral gavage, and 60 min later MitoAzido and MitoOct~*tet*~ were injected. Data are means ± SEM of five mice.\
(D) Complex I activity in the hearts of *Ndufs4*-null mice. Heart mitochondria from *Ndufs4*-null and wild-type control mice were isolated and the complex I activity was measured. Data are means ± SEM of four independent mitochondrial preparations.\
(E) MitoClick formation in the heart of *Ndufs4*-null mice. Mice were injected with MitoAzido and MitoOct and after 1 min MitoClick was analyzed as in (A). Data are mean ± SEM of four mice.\
(F) Citrate synthase activity in the hearts of *Ndufs4*-null mice. Heart mitochondria from *Ndufs4*-null and wild-type control mice were isolated and citrate synthase activity was measured. Data are means ± SEM of 4 independent mitochondrial preparations.\
(G) Δψ~m~ of isolated heart mitochondria from *Ndufs4*-null mice. Heart mitochondria from *Ndufs4*-null and wild-type control mice were incubated with 10 mM succinate, and Δψ~m~ was measured from the distribution of \[^3^H\]-TPMP. Data are means ± SEM of six independent mitochondrial preparations. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
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